CADL
Candel Therapeutics, Inc. Common StockstockNASDAQ
Market OpenNov 19, 2026 9:50:30 AM EST
5.33USD+0.188%(+0.01)105,416
Pre-marketNov 19, 2026 9:21:30 AM EST
5.2839USD-0.679%(-0.0361)
CADL Financials
In Q3 FY 2026 (ended ), Candel Therapeutics, Inc. Common Stock (CADL) reported net income of −$21.87M, operating cash flow of −$23.12M, and assets of $211.11M (filed ).
Loading financial statements…